Sensei Bio
0 followers
Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will be... Read more
Org chart
John K. Celebi
President and CEO
John K. Celebi
Collapse
Erin Colgan
CFO
Christopher Gerry
VP, General Counsel
Hanspeter Waldner
Senior Vice President, Cancer Immunology
Humberto Moran
Vice President of Technical Operations and Maryland Site Lead
Edward Van Der Horst
VP, Preclinical Development
Bao Le
VP, Head of Regulatory Affairs
Elisabeth Colunio
Vice President Human Resources
Kristen Dougherty
Senior Director Program Management
Michael Biega
Senior Director, Head of Investor Relations
Thomas Thisted
Director, Biologics Discovery & Early Development
Donelson Smith
Senior Director, Biologics And Early Development & Translational Sciences
Guolin Zhang
Principal Scientist
Adejumoke Onumajuru
Senior Research Associate
Cassie Fielding
Consulting Research Technician II
Teams
View all
